Ectoparasitic Infestations: Clinical Trials

16 trials for Ectoparasitic Infestations, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 terminated, 1 active not recruiting, 1 not yet recruiting. 16 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 216Completed 12, Terminated 2, Active not recruiting 1, Not yet recruiting 1
Phase 33Completed 2, Terminated 1

Follow Ectoparasitic Infestations: new trials by email Literature Review of Ectoparasitic Infestations trials Research Report on Ectoparasitic Infestations

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)
Ivermectin Tablets - Scabies; Itch, Scabies
Phase 2Active not recruitingMurdoch Childrens Research Institute1202025-06-242026-10-16
Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies
Permethrin Cream, 5%, Ivermectin 200 µg/kg - Scabies
Phase 2Not yet recruitingChildren Hospital and Institute of Child Health, Lahore902025-05-012025-04-20
Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)
CHILD-IVITAB - Scabies
Phase 2CompletedUniversity of Oxford132025-02-252025-12-18
Efficacy and Safety Study of Moxidectin in Adults With Scabies
Moxidectin Oral Product, Placebo - Scabies
Phase 2CompletedMedicines Development for Global Health2002023-11-232026-06-16
Ivermectin Safety in Small Children
Oral ivermectin, Permethrin Cream, Placebo tablet - Scabies
Phase 2CompletedUniversity of Oxford2402023-11-182025-12-18
Dose-finding Study of Moxidectin for Treatment of Scabies
Moxidectin Oral Product - Scabies
Phase 2CompletedMedicines Development for Global Health222020-01-132023-09-22
A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies
Permethrin Foam 4%, Permethrin Foam 5%, Vehicle Foam - Scabies
Phase 2CompletedMylan Inc.1302014-04-012023-04-26
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
Group A - Low-Dose Ha44 0.37% w/w, Group B - High Dose Ha44 Gel 0.74% w/w, Group C - Placebo - Pediculosis
Phase 2CompletedDr. Reddy's Laboratories Limited1422011-04-012020-04-29
Pediatric Head Lice Study Product Comparison
LICEMD, Standard Head lice product - Head Lice
Phase 2CompletedHackensack Meridian Health972009-05-012016-07-29
Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
MALG (malathion) Treatment - Pediculosis
Phase 2 / Phase 3CompletedSun Pharmaceutical Industries, Inc.122008-09-012014-08-07
A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation
Placebo, BGC20-0582 - Pediculus Humanus Capitis, Head Lice
Phase 2CompletedBoston Scientific Corporation2302007-08-012022-06-28
Neem Lotion With Combing for Lice
Neem-based lotion plus louse comb, Neem-based lotion plus grooming comb - Pediculoses, Head Lice
Phase 2CompletedMedical Entomology Centre472006-05-012024-03-19
Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
MALG - Lice Infestations
Phase 2TerminatedSun Pharmaceutical Industries, Inc.302006-02-012013-12-23
A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides.
1) MOOV Head Lice Treatment (Ego Pharmaceutical)., Banlice Mousse Aerosol (Pfizer, Australia), 3) KP24 Medicated Foam (Nelson Laboratories) - Pediculosis
Phase 2 / Phase 3CompletedUniquest Pty Ltd1522004-09-012006-12-12
Comparison of the Efficacy and Safety of Ivermectin to Permethrin
Administration of ivermectin or permethrin - Scabies
Phase 2CompletedUniversity Ghent1602004-07-012007-12-28
Two Treatment Regimens of Cocamide DEA Lotion for Head Lice
cocamide diethanolamine - Pediculosis, Head Louse Infestation
Phase 2 / Phase 3TerminatedMedical Entomology Centre1121999-10-012015-07-16

Narrower conditions

Lice Infestations (8)  ·  Scabies (8)  ·  Neglected Diseases (1)  ·  Parasitic Diseases (1)  ·  Pruritus (1)

Broader conditions

Infections (16)  ·  Skin Diseases (16)  ·  Skin Diseases, Infectious (16)  ·  Skin Diseases, Parasitic (16)  ·  Skin and Connective Tissue Diseases (16)  ·  Parasitic Diseases (15)  ·  Mite Infestations (8)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Skin Manifestations (1)

Interventions

Ivermectin (3)  ·  Malathion (2)  ·  Permethrin (2)  ·  Hexachlorocyclohexane (1)  ·  Therapeutics (1)  ·  coconut diethanolamide (1)

Sponsors

Medical Entomology Centre (2)  ·  Medicines Development for Global Health (2)  ·  Sun Pharmaceutical Industries, Inc. (2)  ·  University of Oxford (2)  ·  Boston Scientific Corporation (1)  ·  Children Hospital and Institute of Child Health, Lahore (1)  ·  Dr. Reddy's Laboratories Limited (1)  ·  Hackensack Meridian Health (1)  ·  Murdoch Childrens Research Institute (1)  ·  Mylan Inc. (1)  ·  Uniquest Pty Ltd (1)  ·  University Ghent (1)

Countries

United States (7)  ·  Australia (2)  ·  Brazil (2)  ·  Dominican Republic (2)  ·  Honduras (2)  ·  Austria (1)  ·  Belgium (1)  ·  El Salvador (1)  ·  France (1)  ·  Kenya (1)  ·  Laos (1)  ·  Pakistan (1)  ·  Puerto Rico (1)  ·  The Gambia (1)  ·  United Kingdom (1)

Top investigators

Ian F Burgess (2)  ·  Amanda Gwee, PhD (1)  ·  Armando Pineda-Velez, MD (1)  ·  Bruce Torkan, MD (1)  ·  Daisy Blanco, MD (1)  ·  Gilberto Perez, MD (1)  ·  Jean-Marie Naeyaert, MD, PhD (1)  ·  Jeffrey Boscamp, MD (1)  ·  Jorge Castillo Molina, MD (1)  ·  Jorge Lopez, MD (1)  ·  Laura B Vargas Rivas, MD (1)  ·  Lawrence Rosen, MD (1)  ·  Lorenz von Seidlein, Ass.Prof. (1)  ·  Lorenz von Seidlein, Dr (1)  ·  Lydie Hazan (1)

Results publications

PMID 17845167, PMID 26092045, PMID 39109221